Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
312.00    0.00 (0.00%)
Bid:
310.00
Ask:
314.00
Spread: 4.00 (1.29%)
Market Cap: £39.59m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

21 Apr 2021 07:00

RNS Number : 0916W
System1 Group PLC
21 April 2021
 

21 April 2021

 

SYSTEM1 GROUP PLC (AIM: SYS1)

("System1", or "the Company", or "the Group")

 

 

Year End Trading Update

 

 

System1 Group, the Advertising Effectiveness Agency, is today providing a Trading Update for its financial year to the end of March 2021 ahead of its results announcement on 29 June 2021.

 

12 MONTHS TO END-MARCH 2021

 

Our Interim Statement released on 17 November 2020 reported that Revenue and Adjusted Profit had recovered substantially since Q1 and that the sales pipeline was strong. This improvement was maintained throughout the second half-year such that Revenue in H2 was approximately 8% above that of the equivalent prior year period, compared with a 26% decline in H1. As a result, the full year Revenue reduction was 11%.

Profitability was stronger in H2 than in H1 as sales picked up faster than adjusted operating costs which were 16% lower than last year in the second half.

We expect to report a pre-tax Adjusted Profit (which excludes impairment, share-based payments, government support, bonuses, loan interest and certain provisions) of some £2.9m for the full year (FY 2019/20: £2.0m). The business continued to generate cash, ending the period with £6.5m cash net of debt versus £4.2m at the previous year end. The net cash figure does not include a £0.5m tax credit for FY 2019/20 which was received early in April 2021.

Underlying the recent improvement is the success of Test Your Ad, System1's first fully automated predictive product set. The transition to automated data products supported by data-enabled, repeatable consultancy products is well underway: data products represented 15% of Sales Revenue in Q4 - mainly Test Your Ad - compared with 1% in H1. We expect the proportion of data product revenues to increase with the rollout in 2021/22 of Test Your Brand.

With the resumption of sales growth and a strong net cash position, the Company will look to reinstate the share buyback programme which was suspended in 2020 due to uncertainty over the potential impact of the Covid pandemic on our business. A return to dividend payments is not currently envisaged. More information will be provided on the proposed buyback later in the year.

 

OUTLOOK

System1 is focused on achieving Revenue growth over the short and medium term. In pursuit of this goal the Company will increase discretionary investment in product development, IT, marketing, and relationships with advertising agencies and advertising platform partners. We will also continue to recruit new talent, after a sizeable increase in headcount during the latter months of 2020/21 which took year-end headcount to 147 from 128 at the half year. The drive for further efficiency improvements in "run" costs will continue. We plan to remain profitable and to continue to generate cash in the 2021/22 financial year, notwithstanding that we are targeting revenue growth to be at least matched by the rate of cost growth as we prioritise scaling our automated predictive products.

 

The Company can be found at https://system1group.com/

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain. 

 

For further information, please contact:

 

System1 Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Founder & Executive President

Stefan Barden, Chief Executive Officer

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTURABRAKUSUAR
Date   Source Headline
24th Mar 20101:22 pmRNSDirector/PDMR Shareholding
10th Mar 20103:11 pmRNSBlocklisting Interim Review
10th Mar 20103:05 pmRNS2009 Final Dividend
10th Mar 20107:38 amRNS2010 Interim Dividend
9th Mar 20107:00 amRNSFinal Results
1st Feb 20107:00 amRNSAlex Batchelor Appointed COO
19th Jan 20107:00 amRNSTrading Update
4th Jan 20102:10 pmRNSShare Dealings
22nd Sep 20097:00 amRNSInterim Dividend
22nd Sep 20097:00 amRNSInterim Results
1st Sep 20097:00 amRNSNotice of Results
8th Jul 200912:46 pmRNSShare Dealings
8th Jul 20097:00 amRNSTrading Statement
13th May 200910:20 amRNSResult of AGM
17th Apr 20097:00 amRNSNotice of AGM
16th Apr 20093:15 pmRNSFinal Dividend
2nd Apr 20097:00 amRNSTrading on Sharemark
19th Mar 20097:00 amRNSPreliminary Results
5th Feb 200910:35 amRNSBlocklisting Interim Review and TVR
19th Jan 20097:00 amRNSPre-Close Trading Statement
13th Jan 200910:41 amRNSDirector's Dealings
9th Jan 20092:18 pmRNSDirector's Dealings
9th Dec 20087:00 amRNSExercise of Share Options
25th Nov 20087:00 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSChange of Adviser
8th Oct 20086:02 pmRNSChange of Adviser Name
5th Sep 20087:00 amRNSInterim Results
4th Aug 20081:08 pmRNSBlocklisting Interim Review
1st Jul 20087:00 amRNSPre-Close Trading Statement
16th Jun 20087:00 amRNSGlobal Expansion
21st May 20084:40 pmRNSResult of AGM
10th Mar 20087:01 amRNSFinal Results
29th Feb 20087:00 amRNSTotal Voting Rights
25th Feb 20087:01 amRNSBlock Listing
12th Feb 20087:00 amRNSNotice of Results
11th Feb 20087:01 amRNSGlobal strategy
15th Jan 20087:00 amRNSTrading update
28th Dec 20074:51 pmRNSDirectors Dealing error
28th Dec 200711:38 amRNSDirectors Dealings
30th Nov 20077:00 amRNSIssue of Equity & TVR
31st Oct 20077:01 amRNSTotal Voting Rights
12th Oct 20077:01 amRNSIssue of Equity
20th Sep 20077:02 amRNSIndustry Award Winner
14th Sep 20071:15 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSInterim Results
5th Sep 20075:44 pmRNSNon-Exec Chairman Appointment
5th Sep 20077:01 amRNSNon-Exec Chairman Appointment
4th Sep 20077:01 amRNSNotice of Results
15th Aug 20078:10 amRNSAIM 26 and NOMAD name change
11th Jun 20077:02 amRNSCreativity Test

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.